RETRACTABLE TECHNOLOGIES, INC. REPORTS FIRST HALF 2007 SALES OF $11.0 MILLION AS UNIT SALES RISE 9.2%

RETRACTABLE TECHNOLOGIES, INC. REPORTS FIRST HALF 2007 SALES

OF $11.0 MILLION AS UNIT SALES RISE 9.2%

ELM, Texas, August 15, 2007 Retractable Technologies, Inc. (AMEX: RVP), a

leading maker of safety needle devices, today reported revenues of $5.3 million

and $11.0 million for the three and six months ended June 30, 2007,

respectively, a decrease from the same 2006 periods. The decline in total

revenues from the year-ago quarter was due largely to lower unit sales and

lower average selling prices in domestic markets. In the first half, overall

unit sales rose 9.2% principally due to higher international unit sales, but

the increase in unit sales was offset by lower average selling prices in the

domestic market. International sales

tend to fluctuate because of the timing of orders under the President s Global

HIV/AIDS initiative.

loss applicable to common shareholders in the second quarter widened to $2.0

million from $567,412 in the same 2006 period. For the first half, the loss

increased to $4.6 million from $1.5 million in 2006. The increased losses for

both periods resulted from lower revenues and higher operating expenses. Operating expenses rose principally because

of higher legal costs. In the second quarter, the gross profit margin increased

to 40.6% from 36.6% in 2006, but declined in the first half to 30.8% from 35.8%

in the same period last year. The

average cost of manufactured product per unit declined in both periods when

compared to the same periods last year.

Company s effective tax rate (a benefit for the three and six months ended June

30, 2006) on the net loss before income taxes were zero in 2007 compared with

49.7 percent and 37.9 percent for the three and six months ended June 30, 2006,

respectively. All tax benefits in 2007 have been fully reserved.

details are available in the Company s Form 10-Q filed on August 14, 2007 with

the Securities and Exchange Commission.

Technologies, Inc. manufactures and markets VanishPoint automated retraction

safety syringes and blood collection devices, which virtually eliminate health

care worker exposure to accidental needlestick injuries. These revolutionary

devices use a patented friction ring mechanism that causes the contaminated

needle to retract automatically from the patient into the barrel of the device,

a feature that is designed to prevent reuse. VanishPoint safety needle devices

are distributed by various specialty and general line distributors. For more

information on Retractable, visit our Web site at www.vanishpoint.com.

statements in this press release are made pursuant to the safe harbor provision

of the Private Securities Litigation Reform Act of 1995 and reflect the Company s

current views with respect to future events. The Company believes that the

expectations reflected in such forward-looking statements are accurate.

However, the Company cannot assure you that such expectations will materialize.

The Company s actual future performance could differ materially from such statements.

that could cause or contribute to such differences include, but are not limited

to: the Company s ability to maintain liquidity; maintenance of the Company s

patent protection; the impact of current litigation; the impact of dramatic

increases in demand; the Company s ability to maintain and quickly increase its

production capacity in the event of a dramatic increase in demand; the Company s

ability to access the market; the Company s ability to maintain or lower

production costs; the Company s ability to continue to finance research and

development as well as operations and expansion of production; the increased

interest of other larger market players, specifically Becton Dickinson and

Company, Inc., in providing safety needle devices to their customers; and other

risks and uncertainties that are detailed from time to time in the Company s

periodic reports filed with the Securities and Exchange Commission.

CONDENSED BALANCE SHEETS

CONDENSED STATEMENTS OF OPERATIONS

Vice President and Chief Financial Officer

(888) 806-2626 or (972) 294-1010

Communications Director

(212) 490-0811 or (214) 912-7415 (cell)